| Primary |
| Product Used For Unknown Indication |
40.7% |
| Hypotension |
11.1% |
| Blood Pressure Management |
7.4% |
| Drug Therapy |
7.4% |
| Blood Pressure |
3.7% |
| Blood Pressure Abnormal |
3.7% |
| Blood Pressure Decreased |
3.7% |
| Blood Pressure Systolic Decreased |
3.7% |
| Drug Use For Unknown Indication |
3.7% |
| Haemodialysis |
3.7% |
| Nephrolithiasis |
3.7% |
| Post Procedural Haemorrhage |
3.7% |
| Sepsis |
3.7% |
|
| Blood Pressure Systolic Decreased |
9.1% |
| Sepsis |
9.1% |
| Chest Pain |
4.5% |
| Drug Ineffective |
4.5% |
| Extravasation |
4.5% |
| Haemorrhage |
4.5% |
| Incorrect Dose Administered |
4.5% |
| Incorrect Drug Administration Rate |
4.5% |
| Infusion Site Warmth |
4.5% |
| Injection Site Necrosis |
4.5% |
| Medication Error |
4.5% |
| Necrosis |
4.5% |
| Oedema Peripheral |
4.5% |
| Poor Peripheral Circulation |
4.5% |
| Product Quality Issue |
4.5% |
| Renal Failure |
4.5% |
| Supraventricular Tachycardia |
4.5% |
| Swelling |
4.5% |
| Thrombocytopenia |
4.5% |
| Unevaluable Event |
4.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
35.3% |
| Product Used For Unknown Indication |
30.2% |
| Hypotension |
6.5% |
| Cardiac Output |
3.9% |
| Vascular Resistance Systemic |
3.9% |
| Abdominal Infection |
3.4% |
| Acute Myocardial Infarction |
2.6% |
| Supraventricular Tachycardia |
2.2% |
| Blood Pressure Management |
1.7% |
| Nodal Rhythm |
1.3% |
| Oropharyngeal Cancer Stage Unspecified |
1.3% |
| Sedation |
1.3% |
| Sepsis |
1.3% |
| Ventricular Tachycardia |
1.3% |
| Anticoagulant Therapy |
0.9% |
| Catheterisation Cardiac |
0.9% |
| Diabetes Mellitus |
0.9% |
| Asthma |
0.4% |
| Bradycardia |
0.4% |
| Gastric Haemorrhage |
0.4% |
|
| Death |
12.9% |
| Sepsis |
12.9% |
| Ventricular Tachycardia |
12.9% |
| Device Failure |
9.7% |
| Therapy Cessation |
6.5% |
| Acute Coronary Syndrome |
3.2% |
| Blood Pressure Fluctuation |
3.2% |
| Device Electrical Finding |
3.2% |
| Hypotension |
3.2% |
| Hypoxia |
3.2% |
| Inflammation |
3.2% |
| Medication Error |
3.2% |
| Overdose |
3.2% |
| Renal Failure |
3.2% |
| Skin Exfoliation |
3.2% |
| Suicide Attempt |
3.2% |
| Tachycardia |
3.2% |
| Thrombocytopenia |
3.2% |
| Wound Infection |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
54.7% |
| Drug Use For Unknown Indication |
18.0% |
| Coronary Artery Bypass |
6.5% |
| Aortic Valve Replacement |
2.9% |
| Adverse Event |
2.1% |
| Multiple Myeloma |
1.8% |
| Catheterisation Cardiac |
1.5% |
| Hypertension |
1.4% |
| Hypotension |
1.3% |
| Mitral Valve Repair |
1.3% |
| Mitral Valve Replacement |
1.3% |
| Pain |
1.2% |
| Prophylaxis |
1.2% |
| Sepsis |
1.1% |
| Pneumonia |
0.9% |
| Cardiac Operation |
0.6% |
| Ventricular Assist Device Insertion |
0.6% |
| Sedation |
0.6% |
| Premedication |
0.6% |
| Heart Transplant |
0.5% |
|
| Unevaluable Event |
10.4% |
| Pain |
10.3% |
| Injury |
9.8% |
| Fear |
8.5% |
| Renal Failure |
6.3% |
| Anxiety |
5.8% |
| Anhedonia |
5.5% |
| Renal Impairment |
4.6% |
| Emotional Distress |
4.5% |
| Sepsis |
4.5% |
| Septic Shock |
4.3% |
| Stress |
3.8% |
| Renal Injury |
3.5% |
| Depression |
3.2% |
| Weight Decreased |
2.8% |
| Death |
2.7% |
| Vomiting |
2.7% |
| Multi-organ Failure |
2.3% |
| Pneumonia |
2.3% |
| Renal Failure Acute |
2.3% |
|
